VP Medicine Development Leader- Oncology
GSK plc
About this role
The Vice President (VP) Medicine Development Leader (MDL) at GSK is responsible for strategically leading the global development of a medicine, acting as the single point of accountability from the early stages through to approval in major markets. This role involves defining the strategic vision and operational plan for the medicine while collaborating with various stakeholders across R&D and Pharma to deliver differentiated medicines of value.
Skills
Qualifications
About GSK plc
gsk.comAt GSK, we unite science, technology and talent to get ahead of disease together
Recent company news
GSKGSK enters agreement to acquire 35Pharma Inc.
2 weeks ago
MarketBeatGSK PLC Sponsored ADR $GSK Shares Sold by Quantbot Technologies LP
5 days ago
TipRanksGSK Adds Elizabeth McKee Anderson to Corporate Responsibility Committee
2 days ago
GSKGSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025
GSKGSK to invest $30 billion in R&D and Manufacturing in the United States over next 5 years
Sep 17, 2025
About GSK plc
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for GSK plc.
Salary
$341k – $568k
per year